Beta Drugs Ltd Quarterly Result

Beta Drugs Ltd Quarterly Result

Image

Beta Drugs Ltd

NSE: BETA

Net Profit - Last Quarter

₹ 9.05 Cr.

Last updated on: Jun 20, 2026

Beta Drugs Ltd Quarterly Results Key Highlights

  • The revenue of Beta Drugs Ltd for the Mar '26 is ₹ 96.86 crore as compare to the Dec '25 revenue of ₹ 89.58 crore.
  • This represent the growth of 8.13% The ebitda of Beta Drugs Ltd for the Mar '26 is ₹ 20.57 crore as compare to the Dec '25 ebitda of ₹ 19.3 crore.
  • This represent the growth of 6.58% The net profit of Beta Drugs Ltd for the Mar '26 is ₹ 9.05 crore as compare to the Dec '25 net profit of ₹ 8.52 crore.
  • This represent the growth of 6.22%.

Beta Drugs Ltd Quarterly Results Analysis

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
19 Jun 20261990.2
18 Jun 20261948.3
17 Jun 20261871.8
16 Jun 20261890.3
15 Jun 20261835.6
12 Jun 20261771.2
11 Jun 20261476
10 Jun 20261503.3
09 Jun 20261522.9
08 Jun 20261430.1

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Beta Drugs Ltd News Hub

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2025. Powered by C

Read more

10 May 25

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be held on 30 Se

Read more

02 Sept 24

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12

Read more

21 Oct 24

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024 Powered b

Read more

04 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

About Beta Drugs Ltd

  • Beta Drugs Limited was incorporated as a private limited company with the name 'Beta Drugs Private limited' at Himachal Pradesh on September 21, 2005.
  • Subsequently, the company was converted in to public limited company and the name of the company was changed to 'Beta Drugs Limited' on August 11, 2017 Beta Drugs is a part of Adley Group.
  • Adley Group was founded in the year 1985, by its promoter Vijay Batra, who has more than twenty five years of experience in manufacture of pharmaceutical products in India.
  • The Company is a pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.
  • The Promoter Vijay Batra, took over the company from Kiran Goyal, Deepak Kumar Prince Bharti and Rohit Bansal in the year 2014.

FAQs for Quarterly Results of Beta Drugs Ltd

What key financial metrics are included in Beta Drugs Ltd's quarterly results?

Key financial metrics in Beta Drugs Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Beta Drugs Ltd announce its quarterly results?

Beta Drugs Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Beta Drugs Ltd's quarterly performance impact its stock price?

Beta Drugs Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Beta Drugs Ltd's quarterly results on dividends?

The impact of Beta Drugs Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Beta Drugs Ltd's quarterly results?

Yes, Beta Drugs Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions